EPIFLO
Oxygen to the wound. Around the clock.
EPIFLO concentrates oxygen from room air with a silent electrochemical fuel-cell concentrator that has no moving parts, and delivers it through a 91 cm sterile cannula placed on the wound bed under a moisture-absorbent dressing and a sealed film or compression wrap. Therapy runs continuously, so the patient stays mobile with no tanks, chambers or separate sessions. Each EPIFLO-28 concentrator lasts 28 days and comes with six sterile cannulas. An indicator light shows device status.
Key specifications
Why the EPIFLO-28
Therapy that never stops
EPIFLO delivers oxygen to the wound bed 24 hours a day for 28 days, instead of in separate treatment sessions.
No tanks, no chamber
A silent electrochemical concentrator makes oxygen from room air. It weighs about four ounces and fits in a pocket or on a strap.
Fits standard dressings
The cannula tip sits on the wound bed under a moisture-absorbent dressing and a sealed film or compression wrap, alongside standard wound care.
Simple to apply
One concentrator and six sterile cannulas per 28-day pack. The cannula twists onto the device port, and an indicator light confirms it is working.
Where it is used
Wound clinics, hospitals, skilled nursing and long-term care, and home care for diabetic, venous stasis and pressure ulcers and gangrenous lesions.
In the box
One 28-day EPIFLO oxygen concentrator and six sterile oxygen delivery cannulas, with the package insert. Dressings, tape and gloves are not included. Pack sizes and configurations are confirmed with the quotation.
Clearance & compliance
FDA 510(k) cleared K190742 (EPIFLO-28, 13 Dec 2019) and K120764 (EPIFLO, 2012); product code KPJ (topical oxygen chamber, extremity); prescription use · CE marked with notified body 2797 and EU authorised representative in Hannover, Germany, per the EPIFLO-28 package insert. Supplied subject to registration in each destination country (MOHAP, DoH, DHA, SFDA or the equivalent authority). Certificates, declarations of conformity, IFUs and registration documents are provided with every quotation. Specifications are indicative and subject to manufacturer change.
Where a country has an official agent or authorised distributor, we source the item through it — or directly from the manufacturer if necessary. Product names, trademarks and images belong to their respective owners.
Questions
Is the EPIFLO-28 available in the UAE and the GCC?
KGG sources EPIFLO-28 on request for wound clinics, hospitals and long-term care providers in the UAE, Saudi Arabia, Qatar, Kuwait, Bahrain and Oman, supplied subject to registration in each destination country. Availability is confirmed with each quotation.
How do I get a price?
Add it to your quote list or use Request a quote. We reply with pricing, lead time and the documents available for your country.
Which wounds is it indicated for?
The EPIFLO-28 insert lists skin ulcerations due to diabetes, venous stasis and pressure ulcers, and gangrenous lesions. It is contraindicated for poorly perfused wounds, wounds covered with eschar or slough, and fistulae or deep sinus tracts of unknown depth.
How long does one device last?
Each EPIFLO-28 concentrator runs for 28 days. Cannulas and dressings are changed with each dressing change and at least once a week, using the six sterile cannulas in the pack.
Can it be stored in Gulf heat?
Ogenix states storage at normal room temperature, avoiding temperatures above 50 °C or below 10 °C, and an operating range of 10–40 °C. Keep stock in air-conditioned storage and out of hot vehicles.
Is it safe around flames?
The device creates an oxygen-rich environment at the wound. Ogenix warns patients not to smoke and to keep away from open flames during treatment.
Request a quote
Get pricing for the EPIFLO-28.
Tell us the quantity, delivery city and whether you are ordering for a facility, a team or a patient. We reply with pricing, lead time and the regulatory documents for your country.
English 
العربية